Enantioselective separation and determination of citalopram enantiomers in pharmaceutical dosage form and bulk drug using experimental design approach on Chiralcel® OC as a chiral stationary phase

• Autorzy: Semreen M. H , Aboul-Enein H. Y.
• Języki publikacji: EN

Abstrakty

EN

An enantioselective HPLC method was developed and validated for the separation and the estimation of citalopram (CIT) enantiomers in bulk drug and pharmaceutical preparations. The method was validated for its linearity (correlation coefficient = 0.9994 and 0.996 for S-(+)-enantiomer and R-(−)-enantiomer, respectively), accuracy, robustness, and intermediate precision. Experimental design was applied during intermediate precision (full factorial 2 ³ design) and robustness testing (Box Benken as a factorial design), for robustness test three factors were considered: percentage of organic modifier, flow rate, and temperature. The separation was achieved on cellulose tris(phenylcarbamate) known as Chiralcel® OC (25 cm, 4.6 mm i.d.) derivatized cellulose (phenyl carbamate), with UV detection at 245 nm using n-hexane-isopropanoldiethylamine (85:15:0.2, υ/υ/υ) as mobile phase at flow rate 0.7 mL min−1. A decrease in the flow rate results in decreasing the selectivity factor (α), while varying the percentage of n-hexane and the temperature have no effect on selectivity factor (α). For intermediate precision, the variables considered were analyst, equipment, and day. The RSD% value (0.73%, n = 24) indicates a good precision for the analytical procedure. The method was found to be suitable for determination of enantiomeric purity of CIT in bulk drugs and pharmaceutical formulations.

Słowa kluczowe

EN

citalopram; enantiomeric purity; cellulose tris(phenylcarbamate) chiral stationary phase; experimental design; enantioselective analysis; stereoselective liquid chromatography; validation

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2011
• Tom: Vol. 23, no. 3
• Strony: 389--401
• Opis fizyczny: Bibliogr. 21 poz., rys., tab.

Twórcy

autor

Semreen M. H

• University of Sharjah College of Pharmacy P.O. Box 27272 Sharjah United Arab Emirates

autor

Aboul-Enein H. Y.

• National Research Centre Pharmaceutical and Medicinal Chemistry Department Dokki, Cairo Egypt

Bibliografia

• [1] P. Baumann, Int. Clin. Psychopharmacol., 11, 5 (1996)
• [2] J. Hyttel, K.P. Bogeso, J. Perregaard, and C. Sanchez, J. Neural Transm. 88, 157 (1992)
• [3] J. Hyttel and J.J. Larsen, Acta Pharmacol. Toxicol., 56, 146 (1985)
• [4] I. Ali, K. Saleem, I. Hussain, V.D. Gaitonde, and H.Y. Aboul-Enein, Separ. Purif. Rev. 38, 97 (2009)
• [5] M. Lammerhofer, O. Gyllenhall, and W. Linder, J. Pharm. Biomed. Anal., 35, 259 (2004)
• [6] A. Bielejewska, K. Duszezyk, and J. Zukoswski, Acta Chromatogr., 15, 183 (2005)
• [7] S. Andersen, T.G. Halvorsen, S.P. Bjergaard, K.E. Rasmussen, L. Tanum, and H. Refsum, J. Pharm. Biomed. Anal., 33, 263 (2003)
• [8] R. Mandrioli, S. Fanali, V. Pucci, and M.A. Raggi, Electrophoresis, 24, 2608 (2003)
• [9] J.S.B. Nevado, C.G. Cabanillas, M.J.V. Llerena, and V.R. Robledo, J. Chromatogr. A, 1072, 249 (2005)
• [10] F.C. Kugelberg, B. Carlsson, J. Ahlner, and F. Bengtsson, Chirality, 15, 622 (2003)
• [11] J. Sidhu, M. Priskom, M. Poulsen, A. Segonzac, G. Grollier, and F. Larsen, Chirality, 9, 686 (1997)
• [12] D. Haupt, J. Chromatogr. B, 685, 299 (1996)
• [13] B. Rochat, M. Amey, and P. Baumann, Ther. Drug Monit., 17, 273 (1995)
• [14] Z. Zheng, M. Jamour, and U. Klotz, Ther. Drug Monit., 22, 219 (2000)
• [15] R. Nageswara, A. Narasa Raju, and D. Nagaraju, J. Pharm. Biomed. Anal., 41, 280 (2006)
• [16] W. Nemrod, D. Mathieu, J. Nony, and R. Phan-Tan-Luu, LPRAI SARL, Marseilles, F-13331 France
• [17] The United States Pharmacopoeia, 24th edn, United States Pharmacopeial Convention: Rockville, MD, 2000, p. 2150
• [18] Y. Van der Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, and D.L. Massart, J. Pharm. Biomed. Anal., 24, 723 (2001)
• [19] G.A. Lewis, D. Mathieu, and R. Phan-Tan-Luu, Pharmaceutical Experimental Design, Marcel Dekker, New York, 1999
• [20] J. Ermera and H.J. Plossb, J. Pharm. Biomed. Anal., 29, 859 (2005)
• [21] International Conferences on Harmonization, Topic Q2Q, Validation of Analytical Methods: Methodology. The Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceutical for Human Use (ICH), Yokohama, Japan, 1997